Daiichi Sankyo Company, Limited
4568Pharmaceuticals
¥2,617.50+1.45%As of Oct 29vs prior close
- Market cap
- $30.1B
- P/E (TTM)
- 19.8×
- P/E (FY1)
- 17.4×
- From 52W high
- −30.13%
- EPS (LTM)
- ¥132.06
- Revenue (LTM)
- ¥2.2T
- Net margin
- 10.93%
- Dividend yield
- 3.40%
Nomior Score
33
Steady ProfileBottom 19% of the scored universe
Growth50
Quality48
Value48
Momentum15
Resilience45
Growth
+18.42%revenue a year over 3 fiscal years
YE23 ¥1.3TLTM ¥2.2T
Connections
Revenue to profitYE26
12% of revenue became net profit, down 3 pts on a year.